tradingkey.logo

Zoetis Inc

ZTS
View Detailed Chart

164.330USD

-4.489-2.66%
Close 06/13, 16:00ETQuotes delayed by 15 min
73.30BMarket Cap
29.48P/E TTM

Zoetis Inc

164.330

-4.489-2.66%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.66%

5 Days

-3.43%

1 Month

+6.07%

6 Months

-7.77%

Year to Date

+0.86%

1 Year

-3.65%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 20 analysts
BUY
Current Rating
197.036
Target Price
19.90%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

167
Total
5
Median
8
Average
Company name
Ratings
Analysts
Zoetis Inc
ZTS
20
Biogen Inc
BIIB
37
Vertex Pharmaceuticals Inc
VRTX
34
Alnylam Pharmaceuticals Inc
ALNY
33
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
1
2
3
...
34

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(9)
Neutral(2)
Buy(2)
Indicators
Sell(5)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-1.021
Neutral
RSI(14)
49.944
Neutral
STOCH(KDJ)(9,3,3)
38.297
Sell
ATR(14)
3.640
Low Volatility
CCI(14)
-100.439
Sell
Williams %R
78.921
Sell
TRIX(12,20)
0.259
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
166.238
Sell
MA10
167.827
Sell
MA20
166.116
Sell
MA50
158.543
Buy
MA100
162.458
Buy
MA200
171.226
Sell

News

More news coming soon, stay tuned...

Company

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Ticker SymbolZTS
CompanyZoetis Inc
CEOMs. Kristin C. Peck
Websitehttps://www.zoetis.com/
KeyAI